Levi A D, Guénard V, Aebischer P, Bunge R P
Miami Project to Cure Paralysis, University of Miami School of Medicine, Florida 33136.
J Neurosci. 1994 Mar;14(3 Pt 1):1309-19. doi: 10.1523/JNEUROSCI.14-03-01309.1994.
The use of human Schwann cells (SCs) in transplantation to promote regeneration in central and peripheral neural tissues must be preceded by efforts to define the factors that regulate their functional expression. Adult-derived human SCs can be isolated and purified in culture, but the culture conditions that allow their full differentiation have not yet been defined. We tested the functional capacity of these cells to enhance axonal regeneration and myelinate regenerating axons in vivo by transplanting them into the damaged PNS of an immune-deficient rat. SCs were purified from human peripheral nerve obtained from organ donors. Semi-permeable guidance channels were filled with a 30% Matrigel containing solution with or without human SCs suspended at a density of 80 x 10(6) cells/ml. Channels were implanted within an 8 mm gap of the transfected sciatic nerve of nude female rats for a period of 4 weeks. Survival of the transplanted human SCs was established by dissociating nerve explants taken from the regenerated cable (after first placing them in culture for 5 d) and staining individual cells for a primate-specific NGF receptor (PNGFr) and S 100. Only one-half of the S 100-positive cells stained for the PNGFr, which indicated that the regenerated cable contained an approximately equal number of human and rat (host) SCs. The presence of some human myelin segments was confirmed by immune staining with an HNK-1 antibody that specifically labels human but not rat myelin. The majority of the myelin segments in the regenerated cable, however, were produced by the rat SCs. The number of myelinated axons and the cross-sectional area of the cable were significantly greater in channels seeded with human SCs when compared to channels containing the diluted Matrigel solution alone. We conclude that purified cultured human SCs can survive and substantially enhance axonal regeneration when transplanted into the injured PNS of an immune-deficient rat. Some of the transplanted human SCs are capable of myelinating regenerating rat axons but are less successful than the host SCs.
在将人雪旺细胞(SCs)用于移植以促进中枢和外周神经组织再生之前,必须先努力确定调节其功能表达的因素。源自成人的人SCs可在培养中分离和纯化,但尚未确定能使其完全分化的培养条件。我们通过将这些细胞移植到免疫缺陷大鼠受损的外周神经系统(PNS)中,测试了它们在体内增强轴突再生和使再生轴突髓鞘化的功能能力。SCs从器官捐献者的人外周神经中纯化获得。半透性引导通道填充有含30%基质胶的溶液,该溶液含有或不含有以80×10⁶细胞/毫升密度悬浮的人SCs。将通道植入裸鼠雌性大鼠转染坐骨神经的8毫米间隙内,持续4周。通过解离取自再生神经束的神经外植体(先在培养中放置5天)并对单个细胞进行灵长类特异性神经生长因子受体(PNGFr)和S100染色,确定移植的人SCs的存活情况。只有一半的S100阳性细胞对PNGFr染色,这表明再生神经束中含有人和大鼠(宿主)SCs的数量大致相等。用特异性标记人而非大鼠髓鞘的HNK - 1抗体进行免疫染色,证实了一些人髓鞘节段的存在。然而,再生神经束中的大多数髓鞘节段是由大鼠SCs产生的。与仅含有稀释基质胶溶液的通道相比,接种人SCs的通道中髓鞘化轴突的数量和神经束的横截面积显著更大。我们得出结论,纯化培养的人SCs移植到免疫缺陷大鼠受损的PNS中时能够存活并显著增强轴突再生。一些移植的人SCs能够使大鼠再生轴突髓鞘化,但不如宿主SCs成功。